Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers
Authors:
- Carmen-Daniela ChivuCCCarmen-Daniela Chivu
- Maria-Dorina CrăciunMCMaria-Dorina Crăciun
- Daniela PițigoiDPDaniela Pițigoi
- Victoria AramăVAVictoria Aramă
- Monica Luminița LuminosMLMonica Luminița Luminos
- Gheorghiță JuguleteGJGheorghiță Jugulete
- Viorela Gabriela NițescuVNViorela Gabriela Nițescu
- Andreea LescaieAndreea Lescaie
- Cătălin Gabriel ApostolescuCACătălin Gabriel Apostolescu
- Adrian Streinu CercelACAdrian Streinu Cercel
Open Access
Abstract
During the coronavirus disease (COVID-19) pandemic healthcare workers (HCWs) acquired immunity by vaccination or exposure to multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our study is a comparative analysis between subgroups of HCWs constructed based on the number of SARS-CoV-2 infections, vaccination, and the dominant variant of SARS-CoV-2 in the population. We collected and analyzed data using the χ2 test and density incidence of reinfections in Microsoft Excel for Mac, Version 16.84, and MedCalc®, 22.026. Of the 829 HCWs, 70.1% (581) had only one SARS-CoV-2 infection and 29.9% (248) had two infections. Of the subjects with two infections, 77.4% (192) worked in high-risk departments and 93.2% (231) of the second infections were registered during Omicron dominance. The density incidence of reinfections was higher in HCWs vaccinated with the primary schedule than those vaccinated with the first booster, and the incidence ratio was 2.8 (95% CI: 1.2; 6.7). The probability of reinfection was five times lower (95% CI: 2.9; 9.2) in HCWs vaccinated with the primary schedule if the first infection was acquired during Omicron dominance. The subjects vaccinated with the first booster had a density incidence of reinfection three times lower (95% CI: 1.9; 5.8) if the first infection was during Omicron. The incidence ratio in subgroups constructed based on characteristics such as gender, age group, job category, and department also registered significant differences in density incidence. The history of SARS-CoV-2 infection by variant is important when interpreting and understanding public health data and the results of studies related to vaccine efficacy for hybrid immunity subgroup populations.Keywords
This publication has 38 references indexed in Scilit:
- Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in SwedenIJID Regions, 2024
- Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge—ORCHESTRA projectInfection, 2024
- Risk of subsequent SARS‐CoV‐2 infection among vaccinated employees with or without hybrid immunity acquired early in the Omicron‐predominant era of the COVID‐19 pandemicAmerican Journal of Industrial Medicine, 2024
- SARS-CoV-2 infection in health care workers during the first 2-years of the pandemic at a cancer hospital in MexicoAmerican Journal of Infection Control, 2023
- Incidence and risk factors related to SARS-CoV-2 infection, reinfection, and seroconversion: Analysis of a healthcare workers cohort from a university hospital in ColombiaIJID Regions, 2023
- Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, ChinaJournal of Medical Virology, 2023
- Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA ProjectJournal of Epidemiology and Global Health, 2023
- Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational studyThe Lancet Regional Health - Europe, 2022
- COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission in New Delhi, IndiaThe Lancet Regional Health - Southeast Asia, 2022
- SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunityEnvironmental Research, 2022